FIFTH EXTENSION - GRANTED
granted
on 09 Aug 2024
Last Applicant/ Owned by
501 Canal Blvd.
Richmond
CA
94804
Serial Number
90420110 filed on 28th Dec 2020
Registration Number
N/A
Correspondent Address
R. Gwen Peterson
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SANGAMO THERAPEUTICS
Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Licensing of intellectual property rights
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90420110
Mark Type
No Service Mark
Attorney Docket Number
No 1225327
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
02.01.33 -
Grotesque men formed by letters, numbers, punctuation or geometric shapes
02.03.26 -
Grotesque women formed by letters, numbers, punctuation or geometric shapes
26.01.04 -
Circles with two breaks or divided in the middle
26.01.17 -
Two concentric circles
26.01.21 -
Circles that are totally or partially shaded
26.17.06 -
Diagonal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Aug 2024 | SOU EXTENSION 5 GRANTED |
| 09th Aug 2024 | SOU EXTENSION 5 FILED |
| 09th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 23rd Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Feb 2024 | SOU EXTENSION 4 FILED |
| 22nd Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 22nd Feb 2024 | SOU EXTENSION 4 GRANTED |
| 22nd Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Aug 2023 | SOU EXTENSION 3 GRANTED |